Prevalence and antibiotic resistance profiles of cerebrospinal fluid pathogens in children with acute bacterial meningitis in Yunnan province, China, 2012-2015

• Published in: PloS one 2017-06, Vol.12 (6), p.e0180161-e0180161
• Main Authors: Jiang, Hongchao, Su, Min, Kui, Liyue, Huang, Hailin, Qiu, Lijuan, Li, Li, Ma, Jing, Du, Tingyi, Fan, Mao, Sun, Qiangming, Liu, Xiaomei
• Format: Article
• Language: English
• Subjects: Acute Disease; Amikacin; Aminoglycosides; Analysis; Anti-Bacterial Agents - therapeutic use; Antibacterial agents; Antibiotic resistance; Antibiotics; Antiinfectives and antibacterials; Antimicrobial agents; Bacteria; Bacteria - classification; Bacteria - drug effects; Bacteria - isolation & purification; Bacterial meningitis; Biology; Biology and Life Sciences; Care and treatment; Cefoxitin; Ceftriaxone; Cephalosporins; Cerebrospinal fluid; Cerebrospinal Fluid - microbiology; Child; Child, Preschool; Children; China; Chloramphenicol; Dosage and administration; Drug resistance; Drug Resistance, Bacterial; Drug therapy; E coli; Epidemiology; Erythromycin; Female; Gentamicin; Gram stain; Gram-negative bacteria; Gram-positive bacteria; Hospitals; Humans; Imipenem; Infant; Infant, Newborn; Infants; Infectious diseases; Linezolid; Listeria; Listeria monocytogenes; Male; Medicine and Health Sciences; Meningitis; Meningitis, Bacterial - cerebrospinal fluid; Meningitis, Bacterial - drug therapy; Microbial drug resistance; Microbial Sensitivity Tests; Mortality; Ofloxacin; Pathogens; Patients; Pediatrics; Penicillin; Piperacillin; R&D; Research & development; Staphylococcus epidermidis; Streptococcus infections; Surveillance; Tazobactam; Vancomycin
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0180161

Acute bacterial meningitis is still considered one of the most dangerous infectious diseases in children. To investigate the prevalence and antibiotic resistance profiles of cerebrospinal fluid (CSF) pathogens in children with acute bacterial meningitis in Southwest China, CSF samples from 179 meningitis patients (3 days to 12 years old) with positive culture results were collected from 2012 to 2015. Isolated pathogens were identified using the Vitek-32 system. Gram stain results were used to guide subcultures and susceptibility testing. The antimicrobial susceptibility of isolates was determined using the disc diffusion method. Of the isolates, 50.8% were Gram-positive bacteria, and 49.2% were Gram-negative bacteria. The most prevalent pathogens were E. coli (28.5%), Streptococcus pneumoniae (17.8%), Staphylococcus epidermidis (10.0%), Haemophilus influenzae type b (9.5%), and group B streptococcus (7.2%). In young infants aged ≤3 months, E. coli was the organism most frequently isolated from CSF (39/76; 51.3%), followed by group B streptococcus (13/76; 17.1%) and Streptococcus pneumoniae (8/76; 10.5%). However, in young infants aged >3 months, the most frequently isolated organism was Streptococcus pneumoniae (24/103; 23.3%), followed by Staphylococcus epidermidis (18/103; 17.5%) and Haemophilus influenzae type b (16/103; 15.5%). Antimicrobial susceptibility tests indicated that for E. coli isolates, the susceptibility rates to aminoglycosides ranged from 56.8% to 100.0%, among them, amikacin was identified as the most effective against E. coli. As for cephalosporins, the susceptibility rates ranged from 29.4% to 78.4%, and cefoxitin was identified as the most effective cephalosporin. In addition, the susceptibility rates of piperacillin/tazobactam and imipenem against E. coli were 86.3% and 100%. Meanwhile, the susceptibility rates of Streptococcus pneumoniae isolates to penicillin G, erythromycin, chloramphenicol, ceftriaxone and tetracycline were 68.8%, 0.0%, 87.5%, 81.3% and 0.0%, respectively. Gentamycin, ofloxacin, linezolid and vancomycin were identified as the most effective antibiotics for Streptococcus pneumoniae, each with susceptibility rates of 100%. It was notable that other emerging pathogens, such as Listeria monocytogenes and group D streptococcus, cannot be underestimated in meningitis.